Skip to main content
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Subscribe
Home
Issues
2023
June 2023 - Vol 16 No 1
2022
December - Vol 15 No 4
September - Vol 15 No 3
June - Vol 15 No 2
March - Vol 15 No 1 - Online Only
Issue Archive
Special Issues
September 2023 Vol 16, Payers' Guide to FDA Updates
Supplements
Special Issue Archive
Topics
Conference Correspondent
Web Exclusives
Web Exclusive Topics
All Web Exclusives
Select Drug Profiles
FDA Approvals
In the News
Press Releases
Videos
Interview with the Innovators
About
About AHDB
Contact Us
Permissions
Editorial Policies
Editorial Board
Editorial Process
Advertising Contacts
Advertising Policy
Reprints
Curtis Wander, PharmD
Clinical Pharmacy Coordinator, SelectHealth, Murray, UT
Authored Items
Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis
Claudio Faria, PharmD, MPH
,
Curtis Wander, PharmD
,
Xuan Li, MS
,
Norman Nagl, PhD
,
Ali McBride, PharmD, MS
January/February 2014 Vol 7, No 1
in
Clinical
Opioid Utilization Patterns Among Medicare Patients with Diabetic Peripheral Neuropathy
Jacqueline Pesa, PhD, MPH
,
Curtis Wander, PharmD
,
Roxanne Meyer, PharmD
,
Tiffany P. Quock, MS, PhD
,
Stacy K. Rattana, RN, BSN
,
Samir H. Mody, PharmD, MBA
May/June 2013 Vol 6, No 4
in
Clinical
Last modified: June 17, 2013
